Evidence map›Paper›PMID 42624349›Full record

ArticleActa biomaterialia2026

Preconditioned endothelialized grafts reduce stenosis and improve vascular remodeling in a rat pulmonary artery model.

Wei Zhang, Qinzhe Xing, Séverine Ménoret, Ignacio Anegon, Yibing Qyang

Abstract read
In one paragraph

Article in Acta biomaterialia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei ZhangYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT, 06511, United States; Yale Stem Cell Center, New Haven, CT, 06520, United States.
Qinzhe XingYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT, 06511, United States; Yale Stem Cell Center, New Haven, CT, 06520, United States.
Séverine MénoretCenter for Research in Transplantation and Translational Immunology UMR1064, INSERM, Nantes Université, Nantes, France; Nantes Université, SFR Santé, Inserm UMS 016, CNRS UMS 3556, Nantes, France.
Ignacio AnegonCenter for Research in Transplantation and Translational Immunology UMR1064, INSERM, Nantes Université, Nantes, France; Nantes Université, SFR Santé, Inserm UMS 016, CNRS UMS 3556, Nantes, France.
Yibing QyangYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT, 06511, United States; Yale Stem Cell Center, New Haven, CT, 06520, United States; Department of Pathology, Yale School of Medicine, New Haven, CT, 06520, United States; Department of Biomedical Engineering, Yale University, New Haven, CT, 06519, United States. Electronic address: yibing.qyang@yale.edu.

Funding

Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical CareR01HL150352 · NHLBI · YALE UNIVERSITY · PI QYANG, YIBING · 2020 to 2023
$2.8M
Readily Available Biological Conduits to Treat Single Ventricle DefectsR01HL171984 · NHLBI · YALE UNIVERSITY · PI Yibing Qyang · 2024 to 2026
$1.7M
Development of HLA engineered universal vascular grafts from human iPSCsR01HL155411 · NHLBI · YALE UNIVERSITY · PI QYANG, YIBING · 2021 to 2024
$1.7M
NHLBI NIH HHS R01 HL150352NHLBI NIH HHS R01 HL155411NHLBI NIH HHS R01 HL171984
6 · The paper itself

Abstract

Pulmonary artery reconstruction is frequently required for congenital heart disease repair, yet current graft options remain limited by the scarcity of autologous conduits and the poor durability of synthetic grafts, which often fail due to thrombosis, stenosis, and calcification. Challenges are exacerbated in the hypoxic, low-pressure pulmonary circulation. Because a functional endothelium is critical for preventing thrombosis and neointimal hyperplasia, we engineered ready-to-use endothelialized tissue-engineered vascular grafts (TEVGs) using a stepwise shear-preconditioning regimen that mimics physiological pulmonary hemodynamics. Human induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) were seeded onto decellularized vascular grafts and conditioned under pulsatile shear stress before implantation. Shear-preconditioned endothelialization improved graft compliance, reduced fibrinogen absorption, and increased endothelial resistance to hypoxic stress in vitro. We then evaluated graft performance in a rat pulmonary artery transplantation model designed to recapitulate the hypoxic and stenosis-prone environment of congenital heart disease. Shear-preconditioned endothelialized grafts maintained patency for one month, supported host cell repopulation, and promoted macrophage-mediated remodeling, whereas all control grafts developed severe stenosis. Patent grafts preserved lung alveolar architecture, while stenotic grafts resulted in exudative lung injury. These findings suggest that shear-preconditioned endothelialization may represent a strategy to generate functional vascular grafts for pulmonary artery reconstruction and establish a physiologically relevant small-animal platform for evaluating TEVG performance in congenital heart diseases. STATEMENT OF SIGNIFICANCE: Limited graft availability and the lack of functional endothelial layer remain key factors contributing to stenosis and graft failure in pulmonary artery reconstruction. Here, we reported development of an endothelialized tissue-engineered vascular graft (TEVG) generated through physiological shear-stress preconditioning to promote endothelial maturation and functional adaptation to the hypoxic, low-pressure pulmonary environment. To evaluate graft performance under physiologically relevant condition, we established a reproducible rat left pulmonary artery transplantation model. Compared with control grafts that developed severe stenosis, shear-preconditioned endothelialized TEVGs maintained luminal patency and showed graft recellularization at one month after implantation. This work presents a shear-preconditioned endothelialization strategy to enhance graft patency and remodeling for pulmonary circulation reconstruction in a physiologically relevant small animal model.

Indexed as

Blood Vessel ProsthesisEndothelial CellsPulmonary ArteryStenosis, Pulmonary ArteryVascular RemodelingAnimalsConstriction, PathologicDisease Models, AnimalHumansInduced Pluripotent Stem CellsMaleRatsRats, Sprague-DawleyEndothelializationPulmonary artery reconstructionShear stressStenosisTissue-engineered vascular graft

Identifiers

PMID42624349
PMCPMC13590204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.